Both are effective treatments for weight loss, however responses to these medications may vary depending on the individual, as with any other medication
If youre ready to take the next step in your diabetes and weight loss journey, Klinic makes it easy to get started
An no se ha empezado a comercializar en Espaa, donde solo est disponible Ozempic, con el mismo principio activo, pero financiado solo para personas con diabetes tipo 2
However, with seven additional Phase 3 trials expected to wrap up in 2026, experts believe it could soon become a major option for people with significant weight loss needsespecially those managing obesity-related joint pain
According to 2024 multi-society guidance (including the American Society of Anesthesiologists), most patients can continue GLP-1 receptor agonists before elective procedures
Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta-analysis